MicroRNA-181c Prevents Apoptosis by Targeting of FAS Receptor in Ewing's Sarcoma Cells

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2018 Mar 23

PMID 29563856

Citations 16

Authors

Masanori Kawano

Kazuhiro Tanaka

Ichiro Itonaga

Tatsuya Iwasaki

Hiroshi Tsumura

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that play important roles in multiple biological processes. Here, we show that miRNAs play an important function in the down-regulation of FAS expression in Ewing's sarcoma (ES) cells.

Methods: To identify and characterize possible oncogenic factors in ES, we employed a microarray-based approach to profile the changes in the expression of miRNAs and their target mRNAs in five ES cell lines and human mesenchymal stem cells (hMSCs).

Results: MiRNA, miR-181c, was significantly up-regulated, whereas FAS receptor expression was significantly down-regulated in all tested ES cells compared with hMSCs. Introducing anti-miR-181c into ES cell lines resulted in an increased expression of FAS2. Additionally, anti-miR-181c prohibited cell growth and cell cycle progression in ES cells. Anti-miR-181c also promoted apoptosis in ES cells. Furthermore, the down-regulation of miR-181c in ES cells significantly suppressed tumor growth in vivo.

Conclusions: These results suggest that unregulated expression of miR-181c could contribute to ES by targeting FAS. Reduction of miR181c increased expression of FAS. This proves that retardation of cell cycle progression removes apoptosis resistance, thereby repressing the growth of Ewing sarcoma. Since FAS signaling is involved in regulation of apoptosis and tumor proliferation, our findings might contribute to new therapeutic targets for ES.

Citing Articles

IL-1 Family Members in Bone Sarcomas.

Landuzzi L, Ruzzi F, Pellegrini E, Lollini P, Scotlandi K, Manara M Cells. 2024; 13(3.

PMID: 38334625 PMC: 10854900. DOI: 10.3390/cells13030233.

Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Kubota Y, Tsumura H Sci Rep. 2023; 13(1):18546.

PMID: 37899376 PMC: 10613623. DOI: 10.1038/s41598-023-45833-6.

Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review.

Hassan M, Shahzadi S, Malik A, Din S, Yasir M, Chun W Genes (Basel). 2023; 14(10).

PMID: 37895198 PMC: 10606885. DOI: 10.3390/genes14101849.

miR-aculous new avenues for cancer immunotherapy.

Tang W, Bauer K, Barba C, Ekiz H, OConnell R Front Immunol. 2022; 13:929677.

PMID: 36248881 PMC: 9554277. DOI: 10.3389/fimmu.2022.929677.

The Biological Function of MicroRNAs in Bone Tumors.

Scuderi S, Calabrese G, Paterniti I, Campolo M, Lanza M, Capra A Int J Mol Sci. 2022; 23(4).

PMID: 35216464 PMC: 8876091. DOI: 10.3390/ijms23042348.

References

Peter M, Budd R, Desbarats J, Hedrick S, Hueber A, Newell M . The CD95 receptor: apoptosis revisited. Cell. 2007; 129(3):447-50. DOI: 10.1016/j.cell.2007.04.031. View

Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller J . NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012; 287(30):25530-40. PMC: 3408167. DOI: 10.1074/jbc.M112.356279. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

Peter M, Hadji A, Murmann A, Brockway S, Putzbach W, Pattanayak A . The role of CD95 and CD95 ligand in cancer. Cell Death Differ. 2015; 22(4):549-59. PMC: 4356349. DOI: 10.1038/cdd.2015.3. View

Chen M, Wang M, Xu S, Guo X, Jiang J . Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Oncotarget. 2015; 6(42):44466-79. PMC: 4792569. DOI: 10.18632/oncotarget.6298. View

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H . MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells. Int J Oncol. 2016; 48(4):1531-40. DOI: 10.3892/ijo.2016.3379. View

Lavrik I, Krammer P . Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 2011; 19(1):36-41. PMC: 3252827. DOI: 10.1038/cdd.2011.155. View

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

10.

Tominaga N, Kosaka N, Ono M, Katsuda T, Yoshioka Y, Tamura K . Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun. 2015; 6:6716. PMC: 4396394. DOI: 10.1038/ncomms7716. View

11.

Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M . The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991; 66(2):233-43. DOI: 10.1016/0092-8674(91)90614-5. View

12.

Stewart T, Abrams S . How tumours escape mass destruction. Oncogene. 2008; 27(45):5894-903. DOI: 10.1038/onc.2008.268. View

13.

Kischkel F, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer P . Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995; 14(22):5579-88. PMC: 394672. DOI: 10.1002/j.1460-2075.1995.tb00245.x. View

14.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

15.

Moore D, Haydon R . Ewing's sarcoma of bone. Cancer Treat Res. 2014; 162:93-115. DOI: 10.1007/978-3-319-07323-1_5. View

16.

Zhang W, Zhang J . miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer. Int J Oncol. 2015; 46(5):2011-20. DOI: 10.3892/ijo.2015.2896. View

17.

Herzog C . Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol. 2005; 27(4):215-8. DOI: 10.1097/01.mph.0000161762.53175.e4. View

18.

Sun J, Shen Q, Lu H, Jiang Z, Xu W, Feng L . Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance. Oncotarget. 2015; 6(39):41997-2007. PMC: 4747204. DOI: 10.18632/oncotarget.6015. View

19.

Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998; 94(4):481-90. DOI: 10.1016/s0092-8674(00)81589-5. View

20.

Cui M, Hou X, Lei X, Mu F, Yang G, Yue L . Upregulation of microRNA 181c expression in gastric cancer tissues and plasma. Asian Pac J Cancer Prev. 2013; 14(5):3063-6. DOI: 10.7314/apjcp.2013.14.5.3063. View